Back to Search Start Over

Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients

Authors :
Emma C. Hulshof
Mirjam de With
Geert-Jan Creemers
Henk-Jan Guchelaar
Ron HJ. Mathijssen
Hans Gelderblom
Maarten J. Deenen
Source :
European Journal of Cancer. 172:231-233
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
09598049
Volume :
172
Database :
OpenAIRE
Journal :
European Journal of Cancer
Accession number :
edsair.doi...........a665fdfa1cdfb6b21a63c6b1d34ab781

Tools

Authors Abstract Subjects Details